×

img Accessibility Controls

Technologies Banner

All Technologies

Recombinant Streptokinase (Rsk) Council of Scientific & Industrial Research (CSIR)'s Second-Generation Clot Buster

Project Overview

This invention pertains to the Process for the production of recombinant streptokinase (Rsk) which is roughly ten times efficient than natural streptokinase. A facile process has been developed to manufacture a recombinant version of natural type streptokinase which is around ten times more efficient than natural streptokinase. Another advantage is its Cost effectiveness.

Quick Information
Thrust Areas
Life Sciences & Biotechnology
Status
Already Commercialised
Output
Status
Already Commercialised
arrowtop
Latest Updates
Loading…